Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

The Trump administration recently nixed a rule proposed by President Biden that would have made it easier for 7.4 million ...

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

While it is understood that the drugs have also proven to be safe and effective for thousands, the negative issues have led ...

As demand soared for weight-loss drugs, price signals worked.

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

The weight-loss drug revolution has arrived, and the food & beverage industry has begun to evolve in response to suppressed ...

CMS has published its final rule for Medicare Advantage and Part D in 2026, outlining a series of regulatory updates aimed at ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

The app hosted at excalidraw.com is a minimal showcase of what you can build with Excalidraw. Its source code is part of this repository as well, and the app features: 📡 PWA support (works offline).

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.

Type 1 diabetes is an autoimmune condition associated with genetics and may develop suddenly. Type 2 diabetes often develops over time, with obesity and a lack of exercise as the main risk factors.